Call for Abstract

28th International Diabetes and Healthcare Conference, will be organized around the theme “Acquainting New Insights of Diabetes & Healthcare”

Diabetic 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Diabetic 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Drug induced diabetes
  • Track 1-2Chemical induced diabetes
  • Track 1-3Nanotechnology and diabetes
  • Track 2-1Medical nutrition therapy
  • Track 2-2Obesity and fatigue
  • Track 2-3Natural products and diabetes
  • Track 3-1Identifying the genes responsible for type 2 diabetes
  • Track 3-2The role of genetics in type 2 diabetes
  • Track 3-3Genetic testing for type 2 diabetes and prevention tips
  • Track 4-1The immune nature of type 1 and type 2 diabetes
  • Track 4-2New strategies for prevention and treatment of type-1 diabetic patients
  • Track 5-1Biomarkers of vascular function in diabetes
  • Track 6-1Mechanisms of action of extracellular signals (hormones, neurotransmitters)
  • Track 6-2Clinical and translational studies related to endocrinology
  • Track 7-1Diabetic ketoacidosis
  • Track 7-2Diabetic neuropathy
  • Track 7-3Cerebral edema
  • Track 8-1Oral drugs lowering glucose levels
  • Track 8-2Insulin, medicines and other diabetes treatments
  • Track 8-3Bariatric surgery
  • Track 8-4Pancreatic islet transplantation
  • Track 9-1Diabetic macular edema
  • Track 9-2Diabetic macular edema
  • Track 9-3Laser photocoagulation
  • Track 10-1Islet cell transplantation
  • Track 10-2Embryonic stem cells
  • Track 10-3Mesenchymal stem cell therapy
  • Track 11-1Cellular regulatory mechanisms involved in hormonal control
  • Track 11-2Ultra-structural aspects related to hormone secretion and action
  • Track 11-3 Cellular regulatory mechanisms involved in hormonal control
  • Track 12-1Elevated blood sugar is related to increased cardiovascular events
  • Track 12-2Cardiometabolic drugs that lower glucose levels
  • Track 12-3Non-glucose lowering medications and their use in diabetics
  • Track 12-4Cardiovascular importance of new diabetes drugs
  • Track 13-1Unexplained weight loss, on-specific malaise
  • Track 13-2Glycosuria in diabetic child
  • Track 14-1Insulin delivery
  • Track 14-2Nanomedicine